Becton Dickinson and Co - Company Profile
Powered by 
All the sales intelligence you need on Becton Dickinson and Co in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Becton Dickinson and Co fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Becton Dickinson and Co.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Becton Dickinson and Co (BD) is a medical technology company. It manufactures and distributes medical supplies, devices, laboratory equipment, and diagnostic products. The company's product portfolio includes vascular and urology devices, surgical products, molecular diagnostic systems, infusion pumps, pre-fillable drug delivery systems, hemodynamic monitoring tools, and cell analysis solutions. BD's products serve healthcare institutions, physicians, life science researchers, clinical labs, the pharmaceutical sector, and the general public. The company has manufacturing operations in various countries, including Bosnia and Herzegovina, Brazil, Canada, the US, the Dominican Republic, France, Germany, Hungary, India, Japan, Mexico and others. BD is headquartered in Franklin Lakes, New Jersey, the US.
Headquarters
United States of America
Address
One Becton Drive, Franklin Lakes, New Jersey, 07417-1880
Website
www.bd.com
Telephone
1 201 8476800
No of Employees
72,000
Industry
Medical Equipment
Ticker Symbol & Exchange
BDX (NYSE)
Revenue (2024)
$21.8B
8.2%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-1.6%
(2024 vs 2023)
Market Cap*
$41.2B
Net Profit Margin (2024)
XYZ
-9.1%
(2024 vs 2023)
* As of and is in US$
Becton Dickinson and Co premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Medication Delivery Solutions: | Atlas |
| Peripheral Intravenous (IV) Catheters | Avitene |
| Advanced Peripheral Catheters | Arista |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In April, the company partnered with Suttons Creek to assist pharmaceutical and biotech companies with the complexities of combination product development. |
| 2026 | Contracts/Agreements | In March, the company signed a partnership with Sinteco for end-to-end connected medication management, making the medication journey easy from hospital receipt all the way to the patient bedside. |
| 2026 | Regulatory Approval | In March, the company received 510(k) clearance from the US Food and Drug Administration for the Surgiphor 1000mL. |
Competitor Comparison
| Key Parameters | Becton Dickinson and Co | Thermo Fisher Scientific Inc | Medtronic Plc | Baxter International Inc | Bio-Rad Laboratories Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Ireland | United States of America | United States of America |
| City | Franklin Lakes | Waltham | Dublin | Deerfield | Hercules |
| State/Province | New Jersey | Massachusetts | - | Illinois | California |
| No. of Employees | 72,000 | 125,000 | 95,000 | 37,500 | 7,450 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Thomas E. Polen | President; Chief Executive Officer; Chairman | Executive Board | 2021 | 51 |
| Vitor Roque | Chief Financial Officer; Executive Vice President | Senior Management | 2026 | - |
| Pamela Spikner | Controller; Senior Vice President; Chief Accounting Officer | Senior Management | 2025 | - |
| Vishy Kanda | Executive Vice President; Chief Strategy Officer | Senior Management | 2022 | - |
| Denise Russell Fleming | Chief Information Officer; Executive Vice President - Technology and Global Services | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer